Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/1991
03/19/1991US5001148 Mevinic acid derivatives
03/19/1991US5001147 Photochemotherapic method of treating psoriasis by using methylangelicin compounds
03/19/1991US5001143 Pharmaceutical composition for prophylactic and preventive of ketosis of livestocks
03/19/1991US5001123 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
03/19/1991US5000953 Biologically active substance
03/19/1991CA2023763A1 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method
03/13/1991EP0417060A2 Bicyclic tetrahydroxypyrrolizidine
03/13/1991EP0417059A2 Bicyclic tetrahydroxylated pyrrolizidines
03/13/1991EP0416773A2 Vitamin B12 composition
03/13/1991EP0416689A2 Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
03/13/1991EP0416578A2 Protein, DNA and use thereof
03/13/1991EP0416479A1 1,5-Benzothiazepine derivatives and preparation thereof
03/13/1991EP0416383A2 Substituted aminopyridines
03/13/1991EP0416232A2 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
03/13/1991EP0416029A1 Procalcitonin peptides
03/13/1991EP0415941A1 Nutrient composition and method for the preparation thereof.
03/13/1991EP0233291B1 2-arylbenzothiazine derivatives
03/12/1991US4999377 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide compounds; dietetics
03/12/1991US4999372 New aminochromanol compounds
03/12/1991US4999341 Appetite moderating and anti-gastritis composition
03/12/1991CA1281326C N-substituted diphenylpiperidines
03/12/1991CA1281322C Substituted pyrimidoindoles
03/10/1991WO1991003481A1 New diphosphonic acid derivatives containing amidine groups, process for preparing them and drugs containing these compounds
03/10/1991WO1991003249A1 Preparations containing colestyramine for reducing lipid levels
03/10/1991CA2066224A1 Amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compounds
03/10/1991CA2065151A1 Preparations containing colestyramine for reducing lipid levels
03/09/1991WO1991003253A1 Treatment of insulin-resistant diabetes
03/09/1991CA2066227A1 Insulin-resistant diabetes
03/09/1991CA2024841A1 Bicyclic tetrahydroxypyrrolizidine
03/09/1991CA2024840A1 Bicyclic tetrahydroxylated pyrrolizidines
03/07/1991WO1991002796A1 Cystic fibrosis gene
03/07/1991WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
03/07/1991WO1991002746A1 Therapeutic peptides
03/07/1991CA2064896A1 Therapeutic peptides
03/07/1991CA2024576A1 Hmg-coa reductase-inhibiting substituted amino-pyridines
03/06/1991EP0415850A1 Bivalent metal salts of 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophene-acid, process for their preparation and pharmaceutical compositions containing them
03/06/1991EP0415605A1 Thiazolidinedione derivatives
03/06/1991EP0415488A2 7-Substituted HMG-COA reductase inhibitors
03/06/1991EP0415487A2 Beta-lactams as anticholesterolemic agents
03/06/1991EP0415458A2 Use of retinoids for preventing and reducing the size of striae distensae lesions
03/06/1991EP0415413A1 Acat inhibitors
03/06/1991EP0415327A1 Vasodilating agent
03/06/1991EP0415018A1 Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations
03/06/1991CN1049665A Carboxylamide derivatives
03/06/1991CN1049663A Pyrroloquinoline compounds
03/06/1991CN1049656A Substitutes n-(quinolin-2-yl-methoxy) benzyl-sulphonyl-ureas
03/05/1991US4997831 Lactam derivatives
03/05/1991US4997828 Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
03/05/1991US4997824 Bone disorders
03/05/1991US4997658 Method for enhancing the lowering of plasma cholesterol levels
03/05/1991US4997657 Linolenic acid/g-/ and di-homo-gamma-linolenic acid
03/01/1991WO1991003170A1 Liquid, stable nutrient containing guar seed flour for oral or parenteral administration
03/01/1991CA2039166A1 Liquid drink and tube food containing stable guar flour
03/01/1991CA2024300A1 Acat inhibitors
03/01/1991CA2024267A1 Beta-lactams as anticholesterolemic agents
03/01/1991CA2024248A1 7-substituted hmg-coa reductase inhibitors
03/01/1991CA2023790A1 1,5-benzothiazepine derivatives and preparation thereof
03/01/1991CA2023435A1 Non-digoxin-like na+, k+-atpase inhibitory factor
02/1991
02/27/1991EP0414490A2 17 Beta-acyl-4-aza-5 alpha-androst-1-ene-3-one as 5 alpha-reductase inhibitors
02/27/1991EP0414421A2 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
02/27/1991EP0414206A2 2,4,6-Substituted phenol derivatives
02/27/1991EP0414080A2 Non-parenteral pharmaceutical compositions for insulin
02/27/1991EP0414023A2 Pyrroloquinoline compounds
02/27/1991EP0414019A2 Subsituted N-(quinolin-2-yl-methoxy)benzylsulfonylureas
02/27/1991CN1049455A Pharmaceutical dosage form improving bioavailability
02/26/1991US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke
02/26/1991US4996235 3,4-diphenylbutanamines
02/26/1991US4996211 Anticonvulsants, treating neurodegenerative diseases
02/26/1991US4996204 Antidiabetic agents
02/26/1991CA2023913A1 Compounds
02/26/1991CA2023905A1 Compounds
02/23/1991CA2023726A1 Pyrroloquinoline compounds
02/22/1991CA2023157A1 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors
02/21/1991WO1991001624A2 Use of calcium antagonists for treating scars
02/21/1991WO1991000725A3 Amino acid analog cck antagonists
02/20/1991EP0413674A2 Phosphorylated glycosidase inhibitor prodrugs
02/20/1991EP0413433A1 Isoindolyl-imidazole-derivatives and pharmaceutical compositions
02/20/1991EP0413383A1 Mutants of human interleukin-3
02/20/1991CN1049348A 2-oxa-1-oxo-8-azaspiro (4,5) decane derivatives, pharmaceutical compositions containing them and process for preparing same
02/20/1991CN1049347A 2-oxa-1-oxo-8-azaspiro ¾4,5 decane derivatives, pharmaceutical compositions containing them and process for preparing same
02/20/1991CN1049343A Substituted 2-imidazolines and preparation and use thereof
02/20/1991CA2023517A1 Substituted n-(quinolin-2-yl-methoxy)benzyl-sulphonyl-urea leukotriene synthesis inhibitors
02/19/1991WO1991002737A1 Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
02/19/1991US4994612 Ylidene sulfonamide derivatives
02/19/1991US4994569 5,6-dihydro-4H-1,3-oxa(or thia)zine derivatives, their preparation and compositions containing them
02/19/1991US4994474 Hypotensive agents
02/19/1991CA2037932A1 Methylenediphosphonic acid compound and anti-inflammatory agent containing the compound as effective component
02/19/1991CA1280421C 1,4-disubstituted piperidinyl derivatives
02/15/1991WO1991003226A2 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
02/15/1991CA2064575A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
02/13/1991EP0412877A1 Oral galenic form to improve bioavailability
02/13/1991EP0412820A2 2-Oxo-1-oxa-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
02/13/1991EP0412604A2 Agglomerated psyllium husk containing edible acid
02/13/1991CN1049165A N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe and phenethylamine derivatives
02/12/1991US4992574 Benzocycloheptene derivatives
02/12/1991US4992530 Treatment of calcium metabolic disorders, cardiac disease and ulcers
02/12/1991US4992462 Inhibitor of HMG-CoA reductase
02/12/1991US4992460 Bicyclic tetrahydroxylated pyrrolizidines
02/12/1991US4992451 1,4-dihydropyridine derivatives
02/12/1991US4992418 Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin